Guardion Health Sciences Announces Launch of acuMMUNE: An Immuno-Supportive/Anti-Oxidant Complex
April 14 2020 - 11:00AM
Guardion Health Sciences, Inc. (“Guardion” or the “Company”)
(Nasdaq: GHSI) announced today that its
immuno-supportive/anti-oxidant complex, labeled acuMMUNETM
(trademark registration pending), is now commercially available.
acuMMUNE is a unique nutraceutical formulation
designed with the objective of supporting effective immune
function. acuMMUNE has been specially formulated with ingredients
that have been shown in studies to support interferon-mediated
anti-viral mechanisms, which are important components of the body’s
immune response during viral infections.*
Michael Favish, CEO of Guardion Health Sciences
commented, “The commercial launch of acuMMUNE is an important
milestone for the Company. As the first Guardion product produced
under our NutriGuard label, we are pleased to offer a product
designed with the objective of supporting effective immune
function. Our internal product and technology design team at
NutriGuard has been working tirelessly towards a successful launch
of this unique product, and we are pleased to be able to provide it
to a wide customer base throughout the United States.”
acuMMUNE was developed as a part of the
NutriGuard™ product line. NutriGuard is the Company’s wholly owned
subsidiary developing high-quality, scientifically credible
nutraceuticals, designed to supplement consumers’ diets and support
healthy immune system functions.
acuMMUNE is being manufactured and packaged in
contract facilities in the United States and is initially being
offered in a capsule form. acuMMUNE is now available for purchase
through the Company’s website (www.guardionhealth.com and
www.nutriguard.com).
* This statement has not been evaluated by
the FDA. This product is not intended to diagnose, treat, cure or
prevent any disease.
About NutriGuardTM
NutriGuardTM formulates high-quality,
scientifically credible nutraceuticals, which are designed to
supplement consumers’ diets and assist in the support of healthy
immune systems. NutriGuard uses high standards to establish the
safety and efficacy of the products it develops and markets, and
also maintains that commitment through rigorous manufacturing and
quality assurance programs. Guardion plans to increase NutriGuard’s
existing customer base and build on its product platform by making
NutriGuard products available to patients directly and through
recommendations by their physicians.
About Guardion Health Sciences, Inc.
Guardion is a specialty health sciences company
(i) that has developed medical foods and medical devices in the
ocular health marketplace and (ii) that is developing
nutraceuticals that the Company believes will provide medicinal and
health benefits to consumers. Information and risk factors with
respect to Guardion and its business, including its ability to
successfully develop and commercialize its proprietary products and
technologies, may be obtained in the Company’s filings with the SEC
at www.sec.gov.
Forward-Looking Statement Disclaimer
With the exception of the historical information
contained in this news release, the matters described herein may
contain forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. Statements
preceded by, followed by or that otherwise include the words
“believes,” “expects,” “anticipates,” “intends,” “projects,”
“estimates,” “plans” and similar expressions or future or
conditional verbs such as “will,” “should,” “would,” “may” and
“could” are generally forward-looking in nature and not historical
facts, although not all forward-looking statements include the
foregoing. These statements involve unknown risks and uncertainties
that may individually or materially impact the matters discussed
herein for a variety of reasons that are outside the control of the
Company, including, but not limited to, the Company’s ability to
raise sufficient financing to implement its business plan and the
Company’s ability to successfully develop and commercialize its
proprietary products and technologies. Readers are cautioned not to
place undue reliance on these forward- looking statements, as
actual results could differ materially from those described in the
forward-looking statements contained herein. Readers are urged to
read the risk factors set forth in the Company’s filings with the
SEC, which are available at the SEC’s website (www.sec.gov). The
Company disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise.
Guardion Health Sciences, Inc.
15150 Avenue of Science, Suite 200 San Diego, CA 92128Phone:
(858) 605-9055Fax: (858) 630-5543www.guardionhealth.com
Investor Relations Contact: Jenene Thomas JTC
Team, LLCTelephone: (833) 475-8247E-Mail: jtc@jtcir.com
Porter, LeVay & Rose, Inc.
Michael PorterTelephone: (212) 564-4700
E-mail: mike@plrinvest.com
Guardion Health Sciences (NASDAQ:GHSI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Guardion Health Sciences (NASDAQ:GHSI)
Historical Stock Chart
From Sep 2023 to Sep 2024